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EGCG inhibited the MMP-2 activity in cell-free assays using HT1080 conditioned medium or the
puriﬁed active enzyme (Fig. 1). Pretreatment with 10 mM EDTA enhanced EGCG-mediated inhibition
of MMP-2 (Fig. 2). Chelating agents alone did not affect MMP-2 activity (Fig. 3).1. Experimental design, materials and methods
1.1. Cell culture
HT1080 human ﬁbrosarcoma cells were obtained from the National Centre for Cell Science, Pune,
India. They were routinely cultured in 25 cm2 ﬂasks (Greiner Bio-one, GmbH, Germany) in a humi-
diﬁed incubator maintained at 37 °C with 5% CO2. Cells were fed with phenol red-containing DMEM,
which was supplemented with 10% FBS (PAA Laboratories, GmbH, Austria), 100 U/mL penicillin and
100 mg/mL streptomycin (HiMedia, Mumbai, India). When conﬂuent, the HT1080 conditioned med-
ium (HT1080-cm), which is a source of gelatinases namely MMP-2 and MMP-9, was aspirated out and
centrifuged at 12,000 rpm for 5 min to remove cell debris. The supernatant (HT1080-cm) was stored
in aliquots at 80 °C until use.2.2. Enzymes and reagents
Active human MMP-2 (EC number 3.4.24.24) was purchased fromMerck Millipore (Cat. no. PF023).
MMP-2 speciﬁc ﬂuorogenic peptide substrate, (MCA-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH2, [MCA¼(7-
methoxycoumarin-4-yl)acetyl; Dpa¼3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl; Nva¼L-norva-
line]) was purchased from Merck Millipore (Product no. 444212), dissolved in 100% DMSO to prepare
a 10 mM stock and stored in small aliquots at 80 °C. ()-Epigallocatechin-3-gallate (EGCG) was
purchased from Sigma-Aldrich (Product no. E4143, St. Louis, MO, USA) and dissolved in 100% ethanol
to prepare a 20 mg/mL (43 mM) stock.
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Fig. 1. Inhibition of MMP-2 activity by EGCG. (A) Aliquots of HT1080-cmwere incubated with indicated concentrations of EGCG
for 45 min at 37 °C and analyzed by gelatin zymography. pro-MMP-2 and pro-MMP-9 activities are indicated by arrows. The
image was analyzed by ImageJ software. The background subtracted integrated density for the MMP-2 band in the control
(0 μM EGCG) was assigned a value of 1 and those obtained for others were expressed relative to control. (B) 10 ng of puriﬁed
active MMP-2 was incubated with indicated concentrations of EGCG in PBS at 37 °C for 45 min followed by gelatin zymography.
The numbers below each lane in the zymograms shown in A and B are relative background-subtracted integrated densities of
MMP-2 bands. (C) Result of the FRET-peptide based ﬂuorogenic substrate assay to determine the effect of EGCG on MMP-2
activity. 10 ng of puriﬁed active MMP-2 was incubated with indicated concentrations of EGCG in the assay buffer at 37 °C for 1 h
followed by assaying for MMP-2 activity based on cleavage of 20 μM MMP-2 speciﬁc ﬂuorogenic peptide substrate. RFU –
relative ﬂuorescence units. Bars represent mean7SD (n¼3). **po0.01, ***po0.001.
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Aliquots of HT1080-cm were mixed with appropriate volumes of EGCG stock solution to maintain
the desired concentrations. Aliquots mixed with equal volume of ethanol alone served as controls.
The mixtures were incubated at 37 °C for 45 min and analyzed by gelatin zymography. Alternatively,
equal quantities (10 ng) of active human MMP-2 were added to a reaction buffer containing indicated
concentrations of EGCG. After incubation at 37 °C for 45 min, the mixtures were analyzed by gelatin
zymography. The effect of EGCG on active MMP-2 was also studied using FRET-peptide based
ﬂuorogenic substrate assay. This assay is based on cleavage of an MMP-2 speciﬁc ﬂuorogenic peptide
substrate. In each well of a 96-well plate, 10 ng of active MMP-2 was mixed with indicated con-
centrations of EGCG in assay buffer (10 mM Tris–HCl at pH 7, 5 mM CaCl2, 1 mM ZnCl2) in a total
volume of 150 mL and incubated at 37 °C for 30 min. This was followed by addition of peptide sub-
strate to a ﬁnal concentration of 20 mM and further incubation of the reaction mixture at 37 °C for 1 h.
Fluorescence was measured using Synergy HT Multimode Microplate reader (BioTeK) using λmax
excitation of 324 nm and λmax emission of 393 nm.
Fig. 2. Effect of divalent cations on inhibition of MMP-2 by EGCG. HT1080-cm (A) or puriﬁed active MMP-2 (B,C) was pre-
treated with EDTA before addition of EGCG at indicated concentrations. The mixtures were then analyzed by gelatin zymo-
graphy (A,B) or FRET-peptide based ﬂuorogenic substrate assay (C). (A) The bar graph is a quantitative representation of pro-
MMP-2 activity (in %) relative to control. Bars represent mean7SD (n¼3). A representative zymogram is shown below. (B) A
representative gelatin zymogram showing the effect of EDTA pretreatment on the activity of puriﬁed MMP-2. The numbers
below the panel indicate relative MMP-2 activity in samples relative to control (set to 1). (C) Result of the FRET-peptide based
ﬂuorogenic substrate assay to study the effect of EDTA pretreatment on puriﬁed MMP-2 activity. Bars represent mean7SD
(n¼3). (D) EGCG was ﬁrst pretreated with 3-fold excess of divalent cations. The mixture was then added to puriﬁed active
MMP-2 followed by analysis of MMP-2 activity by FRET peptide based assay. RFU – relative ﬂuorescence units. *po0.05,
**po0.01, ***po0.001.
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activity
These experiments were performed exactly as described in the previous section except that
HT1080-cm or pure active MMP-2 protein was pre-incubated with indicated concentrations of EDTA
or sodium citrate at 37 °C for 30 min prior to addition of EGCG.
2.5. Gelatin zymography
Gelatin zymography was performed as described earlier with minor modiﬁcations [1]. Samples
were resolved in 7.5% SDS-polyacrylamide gels containing 0.1% gelatin under nondenaturing condi-
tions. The gels were washed in 2.5% Triton X-100 to remove SDS and incubated overnight in the
activation buffer (10 mM Tris–HCl at pH 7, 5 mM CaCl2, 1 mM ZnCl2, and 1.5% Triton X-100). The gels
were stained with 0.5% coomassie brilliant blue followed by destaining with methanol:glacial acetic
acid:water (30:10:60) until clear bands were visible against blue background. The gels were either
scanned or photographed using Kodak gel imaging system. The digital images were analyzed by
Fig. 3. Effect of chelating agents on MMP-2 activity. Aliquots of HT1080-cm were mixed with chelating agents, EDTA (A) or
sodium citrate (B), at indicated concentrations and incubated at 37 °C for 30 min. The mixtures were analyzed by gelatin
zymography. The background subtracted densitometric measurements for pro-MMP-2 bands in control samples (no EDTA or
sodium citrate) were assigned the value of 100 and those obtained in others were expressed as % of control. Bar graphs are
results of three independent experiments. (C) Result of the ﬂuorogenic peptide substrate assay for puriﬁed active MMP-2 in the
presence of indicated concentrations of EDTA. RFU – relative ﬂuorescence units. ns – not signiﬁcant with respect to control.
*po0.05 (n¼3).
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experiments were not treated with 4-aminophenylmercuric acetate (APMA). Hence the bands
detected are of pro-MMP-2 and pro-MMP-9.
2.6. Data presentation and analysis
Bar graphs were plotted in MS Excel. Data were analyzed by R statistical package [3]. ANOVA and
comparison of group means was done using Tukey's test at 5% level of signiﬁcance.Acknowledgements
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